Pharmaceutical

Filter

Current filters:

None

Popular Filters

6626 to 6650 of 7133 results

Medicines are good value for money in UK, says DoH report

24-02-2012

A UK Department of Health released yesterday endorses the current voluntary agreement between the DoH…

EuropeGenericsHealthcarePharmaceuticalPoliticsPricing

GTx stock takes a pounding as FDA puts clinical hold on Capesaris trial

24-02-2012

Tennessee, USA-based GTx (Nasdaq: GTXI) saw its shares plunge 30% to $3.98 earlier this week, after…

CapesarisFinancialGTxNorth AmericaOncologyPharmaceuticalRegulationResearch

Sanofi considers expanding in Ukraine pharma market

24-02-2012

French drug major Sanofi (Euronext: SAN) is considering a massive expansion into the Ukrainian pharmaceutical…

EuropeGenericsMarkets & MarketingPharmaceuticalSanofi

Auxilium and Actelion partner on Xiaflex

24-02-2012

biotech firm, have entered into a long-term partnership for the development, supply and commercialization…

ActelionAuxilium PharmaceuticalsBiotechnologyLicensingPharmaceuticalRare diseasesXiaflex

Roche’s Zelboraf nearly doubles survival in majority of MM patients

23-02-2012

Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the USA and Australia…

OncologyPharmaceuticalResearchRocheZelboraf

Panacea Biotec launches polio vaccine in Nigeria

23-02-2012

Panacea Biotec, India's leading vaccine manufacturer, celebrated the 63rd Indian Republic Day by launching…

Emzor PharmaMarkets & MarketingPanacea BiotecPharmaceuticalPolprotecRest of the WorldVaccines

US FTC updates on Valeant dermatology acquisitions

23-02-2012

Following public comment periods for both transactions, the US Federal Trade Commission has approved…

DermatologicalsMarkets & MarketingPharmaceuticalValeant Pharmaceuticals

FDA advisory panel backs approval of Qnexa

23-02-2012

At last there was finally some good news for drug developer Vivus (Nasdaq: VVUS) - and Americans with…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

EMA approves Shire Vpriv plant in USA

23-02-2012

Ireland-headquartered biopharma firm Shire (LSE: SHP) says that the European Medicines Agency's Committee…

BiotechnologyFinancialNorth AmericaPharmaceuticalRare diseasesRegulationReplagalShireVpriv

Boehringer Ingelheim links with Xencor on MAb supply

23-02-2012

Independent German drug major Boehringer Ingelheim has entered into a collaboration agreement with USA-based,…

BiotechnologyBoehringer IngelheimLicensingPharmaceuticalXencor

PhRMA concerns on South Korea-US FTA

23-02-2012

While overall welcoming the recent Korea-USA Free Trade Agreement (FTA), the Pharmaceutical Research…

Asia-PacificMarkets & MarketingNorth AmericaPharmaceuticalPolitics

Additional indications in Japan for Diagnogreen and Sawacillin

22-02-2012

Japanese drug major Daiichi Sankyo (TYO: 4568) says it has received approval in Japan for a supplemental…

Antibiotics and Infectious diseasesAsia-PacificAstellas PharmaDaiichi SankyoPharmaceuticalRegulationSawacillin

New discovery in fight against Huntington's disease

22-02-2012

Researchers at National University of Ireland Galway have made a significant scientific discovery in…

PharmaceuticalRare diseasesResearch

Enanta Pharma in $440 HCV licensing deal with Novartis

22-02-2012

USA-based discovery and development company Enanta Pharmaceuticals yesterday signed an exclusive collaboration…

Anti-viralsEnanta PharmaceuticalsLicensingNovartisPharmaceutical

Nine news Rx drugs added to Australian PBS listings

22-02-2012

Australia’s Federal Minister for Health, Tanya Plibersek, yesterday announced the listing of nine…

Asia-PacificAstraZenecaBrilintaGlaxoSmithKlinePharmaceuticalPricingRegulationZinnat

Alex Gorsky named as CEO of Johnson & Johnson

22-02-2012

Troubled US health care giant Johnson & Johnson (NYSE: JNJ) last night announced that its board of directors…

Johnson & JohnsonManagementPharmaceutical

NICE backs Roche RoActemra, but with PAS discount

22-02-2012

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has today recommended…

Anti-Arthritics/RheumaticsEuropePharmaceuticalPricingRegulationRoActemraRoche

Ligand licenses DARA Program to Retrophin

21-02-2012

USA-based Ligand Pharmaceuticals (Nasdaq: LGND) has entered into an agreement in which it has licensed…

BiotechnologyDARALicensingLigand PharmaceuticalsNephrology and HepatologyPharmaceuticalRare diseasesResearchRetrophin

Proposal to fund Lilly’s Effient in New Zealand

21-02-2012

PHARMAC, the Pharmaceutical Management Agency of New Zealand, is seeking feedback on a proposal to fund…

Asia-PacificEffientEli LillyPharmaceuticalPricingRegulation

Lanthio Pharma licenses drug to Tarix

21-02-2012

Lanthio Pharma, a privately-held Dutch peptide drug company, says that it has granted USA-based Tarix…

Lanthio PharmaLicensingPharmaceuticalTarix Pharmaceuticals

6626 to 6650 of 7133 results

Back to top